Garmin and ActiGraph are collaborating to create a health and activity monitoring solutions for clinical trials.
The two companies would use Garmin wearables with ActiGraph’s CentrePoint data analytics platform for academic research, clinical trials and remote patient monitoring.
“Garmin Health is excited to work with a global recognized company like ActiGraph that shares an engineering commitment to pioneer high-quality solutions that can be trusted by the scientific community and pharmaceutical market,” Travis Johnson, global product lead of Garmin Health, said in a press release. “Combining the sensor data from Garmin wearables with the data capture and analytical expertise of the ActiGraph platform creates a powerful solution for many different patient monitoring applications.”
ActiGraph currently provides wearable accelerometer monitors and software to create a platform for data monitoring, analysis and management solution. The ActiGraph monitors are used in more than 1,500 pharmaceutical, academic and scientific institutions in 85 countries.
“ActiGraph is excited to work with an innovative company like Garmin,” Jeremy Wyatt, ActiGraph’s chief technology officer and senior VP of product development, said. “Garmin wearables produce high-resolution, accurate data streams that are ideal for scientific analysis and can provide additional, novel endpoints to the ActiGraph software platform. What’s more, the long battery life and ergonomic design of Garmin’s wearables means study participants can comfortably wear the devices for extended periods, leading to improved program adherence and study results.”
Garmin is working toward developing wearables that can detect serious health conditions and suggest that wearables can be important for developing traditional and digital therapeutics. ActiGraph will help Garmin speed up those developments to improve health outcomes.